Akti-1/2

別名：Akt Inhibitor VIII

製品コード：S7776 純度：99.11%

Akti-1/2 (Akt Inhibitor VIII) is a highly selective Akt1/Akt2 inhibitor with IC50 of 58 nM/210 nM, respectively, about 36-fold selectivity for Akt1 over Akt3. Akti-1/2 induces apoptosis.

CAS No. 612847-09-3

サイズ	価格(税別)	在庫状況
10mM (1mL in DMSO)	JPY 29500	国内在庫あり
5mg	JPY 22000	国内在庫あり
25mg	JPY 74500	国内在庫あり
100mg	JPY 145500	国内在庫なし(納期7~10日)
1g	JPY 598500	国内在庫なし(納期7~10日)

代表番号: 045-509-1970\|電子メール：[email protected] よく尋ねられる質問

文献中Selleckの製品使用例（24）

カスタマーフィードバック2例

製品安全説明書

現在のバッチを見る：純度： 99.11%

99.11

Akti-1/2関連製品

関連ターゲット	Akt1 Akt2 Akt3	もっと見る
関連製品	MK-2206 2HCl Perifosine SC79 Capivasertib (AZD5363) GSK690693 Ipatasertib (GDC-0068) Triciribine (API-2) CCT128930 Afuresertib (GSK2110183) A-674563 HCl AT7867 Oridonin PHT-427 TIC10 (ONC201) Miransertib (ARQ 092) HCl AT13148 Uprosertib (GSK2141795) Miransertib (ARQ-092) SC66 Deguelin ML-9 HCl	もっと見る
関連化合物ライブラリー	Kinase Inhibitor Library PI3K/Akt Inhibitor Library Apoptosis Compound Library Cell Cycle compound library NF-κB Signaling Compound Library	もっと見る

シグナル伝達経路

Aktシグナル伝達経路

Akt阻害剤の選択性比較

Cell Data

Cell Lines	Assay Type	活性情報	PMID
ME-180 cell	Growth inhibition assay	Inhibition of human ME-180 cell growth in a cell viability assay, IC50=3.15011 Μm	SANGER
NCI-H526 cells	Growth inhibition assay	Inhibition of Akt-mediated antiapoptotic activity in human NCI-H526 cells assessed as disruption of protein-Apaf-1 complex at 50 uM after 24 hrs by Western blot analysis	17603540
MDA-MB-415 cell	Growth inhibition assay	Inhibition of human MDA-MB-415 cell growth in a cell viability assay, IC50=1.73449 μM	SANGER
MDA-MB-468 cell	Growth inhibition assay	Inhibition of human MDA-MB-468 cell growth in a cell viability assay, IC50=3.70773 μM	SANGER
IGROV-1 cell	Growth inhibition assay	Inhibition of human IGROV-1 cell growth in a cell viability assay, IC50=0.72328 Μm	SANGER
MDA-MB-361 cell	Growth inhibition assay	Inhibition of human MDA-MB-361 cell growth in a cell viability assay, IC50=0.48995 μM	SANGER
HCC70 cell	Growth inhibition assay	Inhibition of human HCC70 cell growth in a cell viability assay, IC50=0.75078 μM	SANGER
HGC-27 cell	Growth inhibition assay	Inhibition of human HGC-27 cell growth in a cell viability assay, IC50=0.15033 μM	SANGER
ETK-1	Growth inhibition assay	Inhibition of human ETK-1 cell growth in a cell viability assay, IC50=4.57383 μM	SANGER
EFM-19 cell	Growth inhibition assay	Inhibition of human EFM-19 cell growth in a cell viability assay, IC50=0.56408 μM	SANGER
EFO-21 cell	Growth inhibition assay	Inhibition of human EFO-21 cell growth in a cell viability assay, IC50=4.43468 μM	SANGER
ECC12 cell	Growth inhibition assay	Inhibition of human ECC12 cell growth in a cell viability assay, IC50=8.88569 μM	SANGER
DSH1 cell	Growth inhibition assay	Inhibition of human DSH1 cell growth in a cell viability assay, IC50=0.98722 μM	SANGER
DOK cell	Growth inhibition assay	Inhibition of human DOK cell growth in a cell viability assay, IC50=4.15134 μM	SANGER
DMS-273 cell	Growth inhibition assay	Inhibition of human DMS-273 cell growth in a cell viability assay, IC50=4.15134 μM	SANGER
Calu-3 cell	Growth inhibition assay	Inhibition of human Calu-3 cell growth in a cell viability assay, IC50=3.65321 μM	SANGER
Calu-1 cell	Growth inhibition assay	Inhibition of human Calu-1 cell growth in a cell viability assay, IC50=7.25613 μM	SANGER
Ca9-22 cell	Growth inhibition assay	Inhibition of human Ca9-22 cell growth in a cell viability assay, IC50=5.97333 μM	SANGER
Ca-Ski cell	Growth inhibition assay	Inhibition of human Ca-Ski cell growth in a cell viability assay, IC50=5.3411 μM	SANGER
CTB-1 cell	Growth inhibition assay	Inhibition of human CTB-1 cell growth in a cell viability assay, IC50=7.59751 μM	SANGER
COR-L279 cell	Growth inhibition assay	Inhibition of human COR-L279 cell growth in a cell viability assay, IC50=1.68064 μM	SANGER
COLO-205 cell	Growth inhibition assay	Inhibition of human COLO-205 cell growth in a cell viability assay, IC50=1.99706 μM	SANGER
CHP-212 cell	Growth inhibition assay	Inhibition of human CHP-212 cell growth in a cell viability assay, IC50=4.55867 μM	SANGER
CESS cell	Growth inhibition assay	Inhibition of human CESS cell growth in a cell viability assay, IC50=2.70089 μM	SANGER
CCRF-CEM cell	Growth inhibition assay	Inhibition of human CCRF-CEM cell growth in a cell viability assay, IC50=4.93541 μM	SANGER
CCF-STTG1 cell	Growth inhibition assay	Inhibition of human CCF-STTG1 cell growth in a cell viability assay, IC50=6.81501 μM	SANGER
YKG-1 cell	Growth inhibition assay	Inhibition of human YKG-1 cell growth in a cell viability assay, IC50=1.01806 μM	SANGER
VMRC-RCZ cell	Growth inhibition assay	Inhibition of human VMRC-RCZ cell growth in a cell viability assay, IC50=3.70955 μM	SANGER
UACC-893 cell	Growth inhibition assay	Inhibition of human UACC-893 cell growth in a cell viability assay, IC50=5.29339 μM	SANGER
UACC-62 cell	Growth inhibition assay	Inhibition of human UACC-62 cell growth in a cell viability assay, IC50=27.0545 μM	SANGER
U251 cell	Growth inhibition assay	Inhibition of human U251 cell growth in a cell viability assay, IC50=19.204 μM	SANGER
U-698-M cell	Growth inhibition assay	Inhibition of human U-698-M cell growth in a cell viability assay, IC50=39.0015 μM	SANGER
U-118-MG cell	Growth inhibition assay	Inhibition of human U-118-MG cell growth in a cell viability assay, IC50=9.90258 μM	SANGER
TT cell	Growth inhibition assay	Inhibition of human TT cell growth in a cell viability assay, IC50=5.32724 μM	SANGER
TE-8 cell	Growth inhibition assay	Inhibition of human TE-8 cell growth in a cell viability assay, IC50=24.5243 μM	SANGER
TE-5 cell	Growth inhibition assay	Inhibition of human TE-5 cell growth in a cell viability assay, IC50=4.82452 μM	SANGER
TE-15 cell	Growth inhibition assay	Inhibition of human TE-15 cell growth in a cell viability assay, IC50=6.49393 μM	SANGER
TE-10 cell	Growth inhibition assay	Inhibition of human TE-10 cell growth in a cell viability assay, IC50=9.04225 μM	SANGER
CAL-85-1 cell	Growth inhibition assay	Inhibition of human CAL-85-1 cell growth in a cell viability assay, IC50=5.95309 μM	SANGER
CAL-54 cell	Growth inhibition assay	Inhibition of human CAL-54 cell growth in a cell viability assay, IC50=4.88625 μM	SANGER
CAL-51 cell	Growth inhibition assay	Inhibition of human CAL-51 cell growth in a cell viability assay, IC50=7.62841 Μm	SANGER
CAL-33 cell	Growth inhibition assay	Inhibition of human CAL-33 cell growth in a cell viability assay, IC50=3.43125 μM	SANGER
C3A cell	Growth inhibition assay	Inhibition of human C3A cell growth in a cell viability assay, IC50=4.42192 μM	SANGER
C2BBe1 cell	Growth inhibition assay	Inhibition of human C2BBe1 cell growth in a cell viability assay, IC50=13.6679 μM	SANGER
C-33-A cell	Growth inhibition assay	Inhibition of human C-33-A cell growth in a cell viability assay, IC50=12.4783 μM	SANGER
BxPC-3 cell	Growth inhibition assay	Inhibition of human BxPC-3 cell growth in a cell viability assay, IC50=2.22442 μM	SANGER
BB30-HNC cell	Growth inhibition assay	Inhibition of human BB30-HNC cell growth in a cell viability assay, IC50=2.86449 μM	SANGER
AU565 cell	Growth inhibition assay	Inhibition of human AU565 cell growth in a cell viability assay, IC50=1.23917 μM	SANGER
AN3-CA cell	Growth inhibition assay	Inhibition of human AN3-CA cell growth in a cell viability assay, IC50=1.65611 μM	SANGER
A498 cell	Growth inhibition assay	Inhibition of human A498 cell growth in a cell viability assay, IC50=1.08134 μM	SANGER
A427 cell	Growth inhibition assay	Inhibition of human A427 cell growth in a cell viability assay, IC50=3.07693 μM	SANGER
A4-Fuk cell	Growth inhibition assay	Inhibition of human A4-Fuk cell growth in a cell viability assay, IC50=1.8583 μM	SANGER
8-MG-BA cell	Growth inhibition assay	Inhibition of human 8-MG-BA cell growth in a cell viability assay, IC50=8.63401 μM	SANGER
769-P cell	Growth inhibition assay	Inhibition of human 769-P cell growth in a cell viability assay, IC50=1.10483 μM	SANGER
697 cell	Growth inhibition assay	Inhibition of human 697 cell growth in a cell viability assay, IC50=7.17746 μM	SANGER
639-V cell	Growth inhibition assay	Inhibition of human 639-V cell growth in a cell viability assay, IC50=5.8773 μM	SANGER
23132-87 cell	Growth inhibition assay	Inhibition of human 23132-87 cell growth in a cell viability assay, IC50=0.75938 μM	SANGER
22RV1 cell	Growth inhibition assay	Inhibition of human 22RV1 cell growth in a cell viability assay, IC50=6.61424 μM	SANGER
T47D cell	Growth inhibition assay	Inhibition of human T47D cell growth in a cell viability assay, IC50=0.5162 μM	SANGER
SW954 cell	Growth inhibition assay	Inhibition of human SW954 cell growth in a cell viability assay, IC50=5.85783 μM	SANGER
SW872 cell	Growth inhibition assay	Inhibition of human SW872 cell growth in a cell viability assay, IC50=14.1435 μM	SANGER
SW780 cell	Growth inhibition assay	Inhibition of human SW780 cell growth in a cell viability assay, IC50=4.89358 μM	SANGER
SW1710 cell	Growth inhibition assay	Inhibition of human SW1710 cell growth in a cell viability assay, IC50=1.38892 μM	SANGER
SU-DHL-1 cell	Growth inhibition assay	Inhibition of human SU-DHL-1 cell growth in a cell viability assay, IC50=6.81543 μM	SANGER
SR cell	Growth inhibition assay	Inhibition of human SR cell growth in a cell viability assay, IC50=13.0746 μM	SANGER
SNU-C2B cell	Growth inhibition assay	Inhibition of human SNU-C2B cell growth in a cell viability assay, IC50=22.2673 μM	SANGER
SNU-C1 cell	Growth inhibition assay	Inhibition of human SNU-C1 cell growth in a cell viability assay, IC50=2.00948 μM	SANGER
SNU-423 cell	Growth inhibition assay	Inhibition of human SNU-423 cell growth in a cell viability assay, IC50=5.94933 μM	SANGER
SNU-387 cell	Growth inhibition assay	Inhibition of human SNU-387 cell growth in a cell viability assay, IC50=4.19544 μM	SANGER
SNB75 cell	Growth inhibition assay	Inhibition of human SNB75 cell growth in a cell viability assay, IC50=7.8297 μM	SANGER
human SN12C cell	Growth inhibition assay	Inhibition of human SN12C cell growth in a cell viability assay, IC50=17.1967 μM	SANGER
SK-MES-1 cell	Growth inhibition assay	Inhibition of human SK-MES-1 cell growth in a cell viability assay, IC50=2.10096 μM	SANGER
SK-MEL-3 cell	Growth inhibition assay	Inhibition of human SK-MEL-3 cell growth in a cell viability assay, IC50=21.4696 μM	SANGER
SK-MEL-24 cell	Growth inhibition assay	Inhibition of human SK-MEL-24 cell growth in a cell viability assay, IC50=13.1675 μM	SANGER
SK-LU-1 cell	Growth inhibition assay	Inhibition of human SK-LU-1 cell growth in a cell viability assay, IC50=42.043 μM	SANGER
SK-LMS-1 cell	Growth inhibition assay	Inhibition of human SK-LMS-1 cell growth in a cell viability assay, IC50=8.76452 μM	SANGER
SK-CO-1 cell	Growth inhibition assay	Inhibition of human SK-CO-1 cell growth in a cell viability assay, IC50=10.6394 μM	SANGER
SJSA-1 cell	Growth inhibition assay	Inhibition of human SJSA-1 cell growth in a cell viability assay, IC50=36.9072 μM	SANGER
SIG-M5 cell	Growth inhibition assay	Inhibition of human SIG-M5 cell growth in a cell viability assay, IC50=12.6604 μM	SANGER
SF295 cell	Growth inhibition assay	Inhibition of human SF295 cell growth in a cell viability assay, IC50=13.6183 μM	SANGER
SF268 cell	Growth inhibition assay	Inhibition of human SF268 cell growth in a cell viability assay, IC50=15.1387 μM	SANGER
SF126 cell	Growth inhibition assay	Inhibition of human SF126 cell growth in a cell viability assay, IC50=10.6746 μM	SANGER
SCC-9 cell	Growth inhibition assay	Inhibition of human SCC-9 cell growth in a cell viability assay, IC50=3.08536 μM	SANGER
SCC-4 cell	Growth inhibition assay	Inhibition of human SCC-4 cell growth in a cell viability assay, IC50=9.59283 μM	SANGER
SCC-25 cell	Growth inhibition assay	Inhibition of human SCC-25 cell growth in a cell viability assay, IC50=15.8179 μM	SANGER
SBC-5 cell	Growth inhibition assay	Inhibition of human SBC-5 cell growth in a cell viability assay, IC50=20.8325 μM	SANGER
RXF393 cell	Growth inhibition assay	Inhibition of human RXF393 cell growth in a cell viability assay, IC50=20.5863 μM	SANGER
RVH-421 cell	Growth inhibition assay	Inhibition of human RVH-421 cell growth in a cell viability assay, IC50=32.3606 μM	SANGER
RT-112 cell	Growth inhibition assay	Inhibition of human RT-112 cell growth in a cell viability assay, IC50=6.71952 μM	SANGER
RS4-11 cell	Growth inhibition assay	Inhibition of human RS4-11 cell growth in a cell viability assay, IC50=6.68645 μM	SANGER
RPMI-8402 cell	Growth inhibition assay	Inhibition of human RPMI-8402 cell growth in a cell viability assay, IC50=16.343 μM	SANGER
RPMI-2650 cell	Growth inhibition assay	Inhibition of human RPMI-2650 cell growth in a cell viability assay, IC50=5.77947 μM	SANGER
RO82-W-1 cell	Growth inhibition assay	Inhibition of human RO82-W-1 cell growth in a cell viability assay, IC50=47.2783 μM	SANGER
RKO cell	Growth inhibition assay	Inhibition of human RKO cell growth in a cell viability assay, IC50=19.4439 μM	SANGER
RERF-LC-MS cell	Growth inhibition assay	Inhibition of human RERF-LC-MS cell growth in a cell viability assay, IC50=26.1347 μM	SANGER
REH cell	Growth inhibition assay	Inhibition of human REH cell growth in a cell viability assay, IC50=11.4883 μM	SANGER
RD cell	Growth inhibition assay	Inhibition of human RD cell growth in a cell viability assay, IC50=20.6036 μM	SANGER
RCC10RGB cell	Growth inhibition assay	Inhibition of human RCC10RGB cell growth in a cell viability assay, IC50=8.6567 μM	SANGER
PF-382 cell	Growth inhibition assay	Inhibition of human PF-382 cell growth in a cell viability assay, IC50=11.6828 μM	SANGER
PC-3 cell	Growth inhibition assay	Inhibition of human PC-3 cell growth in a cell viability assay, IC50=10.5135 μM	SANGER
PANC-10-05 cell	Growth inhibition assay	Inhibition of human PANC-10-05 cell growth in a cell viability assay, IC50=14.9959 μM	SANGER
PANC-03-27 cell	Growth inhibition assay	Inhibition of human PANC-03-27 cell growth in a cell viability assay, IC50=8.71082 μM	SANGER
PA-1 cell	Growth inhibition assay	Inhibition of human PA-1 cell growth in a cell viability assay, IC50=9.07615 μM	SANGER
P30-OHK cell	Growth inhibition assay	Inhibition of human P30-OHK cell growth in a cell viability assay, IC50=4.536 μM	SANGER
P12-ICHIKAWA cell	Growth inhibition assay	Inhibition of human P12-ICHIKAWA cell growth in a cell viability assay, IC50=14.7683 μM	SANGER
OVCAR-4 cell	Growth inhibition assay	Inhibition of human OVCAR-4 cell growth in a cell viability assay, IC50=30.466 μM	SANGER
OVCAR-3 cell	Growth inhibition assay	Inhibition of human OVCAR-3 cell growth in a cell viability assay, IC50=1.84415 μM	SANGER
OS-RC-2 cell	Growth inhibition assay	Inhibition of human OS-RC-2 cell growth in a cell viability assay, IC50=8.52307 μM	SANGER
OMC-1 cell	Growth inhibition assay	Inhibition of human OMC-1 cell growth in a cell viability assay, IC50=9.25098 μM	SANGER
OE33 cell	Growth inhibition assay	Inhibition of human OE33 cell growth in a cell viability assay, IC50=1.88926 μM	SANGER
OE19 cell	Growth inhibition assay	Inhibition of human OE19 cell growth in a cell viability assay, IC50=7.76684 μM	SANGER
OCUB-M cell	Growth inhibition assay	Inhibition of human OCUB-M cell growth in a cell viability assay, IC50=7.72152 μM	SANGER
OCI-AML2 cell	Growth inhibition assay	Inhibition of human OCI-AML2 cell growth in a cell viability assay, IC50=33.2531 μM	SANGER
OAW-42 cell	Growth inhibition assay	Inhibition of human OAW-42 cell growth in a cell viability assay, IC50=7.31565 μM	SANGER
NY cell	Growth inhibition assay	Inhibition of human NY cell growth in a cell viability assay, IC50=31.1864 μM	SANGER
NUGC-3 cell	Growth inhibition assay	Inhibition of human NUGC-3 cell growth in a cell viability assay, IC50=16.5906 μM	SANGER
NOS-1 cell	Growth inhibition assay	Inhibition of human NOS-1 cell growth in a cell viability assay, IC50=1.36953 μM	SANGER
NMC-G1 cell	Growth inhibition assay	Inhibition of human NMC-G1 cell growth in a cell viability assay, IC50=42.6693 μM	SANGER
NKM-1 cell	Growth inhibition assay	Inhibition of human NKM-1 cell growth in a cell viability assay, IC50=2.75923 μM	SANGER
NH-12 cell	Growth inhibition assay	Inhibition of human NH-12 cell growth in a cell viability assay, IC50=0.60864 μM	SANGER
NCI-N87 cell	Growth inhibition assay	Inhibition of human NCI-N87 cell growth in a cell viability assay, IC50=29.3042 μM	SANGER
NCI-H838 cell	Growth inhibition assay	Inhibition of human NCI-H838 cell growth in a cell viability assay, IC50=31.4118 μM	SANGER
NCI-H747 cell	Growth inhibition assay	Inhibition of human NCI-H747 cell growth in a cell viability assay, IC50=7.62799 μM	SANGER
NCI-H661 cell	Growth inhibition assay	Inhibition of human NCI-H661 cell growth in a cell viability assay, IC50=5.42326 μM	SANGER
NCI-H650 cell	Growth inhibition assay	Inhibition of human NCI-H650 cell growth in a cell viability assay, IC50=7.59877 μM	SANGER
NCI-H64 cell	Growth inhibition assay	Inhibition of human NCI-H64 cell growth in a cell viability assay, IC50=12.5431 μM	SANGER
NCI-H630 cell	Growth inhibition assay	Inhibition of human NCI-H630 cell growth in a cell viability assay, IC50=5.51055 μM	SANGER
NCI-H596	Growth inhibition assay	Inhibition of human NCI-H596 cell growth in a cell viability assay, IC50=17.5708 μM	SANGER
NCI-H526 cell	Growth inhibition assay	Inhibition of human NCI-H526 cell growth in a cell viability assay, IC50=22.8873μM	SANGER
NCI-H522 cell	Growth inhibition assay	Inhibition of human NCI-H522 cell growth in a cell viability assay, IC50=11.0874 μM	SANGER
NCI-H520 cell	Growth inhibition assay	Inhibition of human NCI-H520 cell growth in a cell viability assay, IC50=1.13303 μM	SANGER
NCI-H460 cell	Growth inhibition assay	Inhibition of human NCI-H460 cell growth in a cell viability assay, IC50=4.62993 μM	SANGER
NCI-H358 cell	Growth inhibition assay	Inhibition of human NCI-H358 cell growth in a cell viability assay, IC50=19.7233 μM	SANGER
NCI-H345 cell	Growth inhibition assay	Inhibition of human NCI-H345 cell growth in a cell viability assay, IC50=16.2706 μM	SANGER
NCI-H292 cell	Growth inhibition assay	Inhibition of human NCI-H292 cell growth in a cell viability assay, IC50=6.04837 μM	SANGER
NCI-H2452 cell	Growth inhibition assay	Inhibition of human NCI-H2452 cell growth in a cell viability assay, IC50=26.6594 μM	SANGER
NCI-H2405 cell	Growth inhibition assay	Inhibition of human NCI-H2405 cell growth in a cell viability assay, IC50=10.4212 μM	SANGER
NCI-H2347 cell	Growth inhibition assay	Inhibition of human NCI-H2347 cell growth in a cell viability assay, IC50=16.1581 μM	SANGER
NCI-H2342 cell	Growth inhibition assay	Inhibition of human NCI-H2342 cell growth in a cell viability assay, IC50=0.93779 μM	SANGER
NCI-H2228 cell	Growth inhibition assay	Inhibition of human NCI-H2228 cell growth in a cell viability assay, IC50=2.28604 μM	SANGER
NCI-H2196 cell	Growth inhibition assay	Inhibition of human NCI-H2196 cell growth in a cell viability assay, IC50=24.8003 μM	SANGER
NCI-H2170 cell	Growth inhibition assay	Inhibition of human NCI-H2170 cell growth in a cell viability assay, IC50=18.1028 μM	SANGER
NCI-H2126 cell	Growth inhibition assay	Inhibition of human NCI-H2126 cell growth in a cell viability assay, IC50=12.3371 μM	SANGER
NCI-H2122 cell	Growth inhibition assay	Inhibition of human NCI-H2122 cell growth in a cell viability assay, IC50=10.1385 μM	SANGER
NCI-H2030 cell	Growth inhibition assay	Inhibition of human NCI-H2030 cell growth in a cell viability assay, IC50=1.94483 μM	SANGER
NCI-H2009 cell	Growth inhibition assay	Inhibition of human NCI-H2009 cell growth in a cell viability assay, IC50=7.39019 μM	SANGER
NCI-H1993 cell	Growth inhibition assay	Inhibition of human NCI-H1993 cell growth in a cell viability assay, IC50=22.615 μM	SANGER
NCI-H1963 cell	Growth inhibition assay	Inhibition of human NCI-H1963 cell growth in a cell viability assay, IC50=19.7494 μM	SANGER
NCI-H1792 cell	Growth inhibition assay	Inhibition of human NCI-H1792 cell growth in a cell viability assay, IC50=29.8379 μM	SANGER
NCI-H1770 cell	Growth inhibition assay	Inhibition of human NCI-H1770 cell growth in a cell viability assay, IC50=34.1793 μM	SANGER
NCI-H1755 cell	Growth inhibition assay	Inhibition of human NCI-H1755 cell growth in a cell viability assay, IC50=1.05531 μM	SANGER
NCI-H1734 cell	Growth inhibition assay	Inhibition of human NCI-H1734 cell growth in a cell viability assay, IC50=10.7788 μM	SANGER
NCI-H1703 cell	Growth inhibition assay	Inhibition of human NCI-H1703 cell growth in a cell viability assay, IC50=15.577 μM	SANGER
NCI-H1651 cell	Growth inhibition assay	Inhibition of human NCI-H1651 cell growth in a cell viability assay, IC50=16.4338 μM	SANGER
NCI-H1650 cell	Growth inhibition assay	Inhibition of human NCI-H1650 cell growth in a cell viability assay, IC50=11.5134 μM	SANGER
NCI-H1648 cell	Growth inhibition assay	Inhibition of human NCI-H1648 cell growth in a cell viability assay, IC50=5.7551 μM	SANGER
NCI-H1623 cell	Growth inhibition assay	Inhibition of human NCI-H1623 cell growth in a cell viability assay, IC50=15.0596 μM	SANGER
NCI-H1618 cel	Growth inhibition assay	Inhibition of human NCI-H1618 cell growth in a cell viability assay, IC50=21.9982 μM	SANGER
ES7 cell	Growth inhibition assay	Inhibition of human ES7 cell growth in a cell viability assay, IC50=1.34511 μM	SANGER
EW-3 cell	Growth inhibition assay	Inhibition of human EW-3 cell growth in a cell viability assay, IC50=5.64414 μM	SANGER
EB2 cell	Growth inhibition assay	Inhibition of human EB2 cell growth in a cell viability assay, IC50=7.75468 μM	SANGER
DoTc2-4510 cell	Growth inhibition assay	Inhibition of human DoTc2-4510 cell growth in a cell viability assay, IC50=3.43202 μM	SANGER
Detroit562 cell	Growth inhibition assay	Inhibition of human Detroit562 cell growth in a cell viability assay, IC50=4.79465 μM	SANGER
DV-90 cell	Growth inhibition assay	Inhibition of human DV-90 cell growth in a cell viability assay, IC50=6.03122 μM	SANGER
NCI-H1563 cell	Growth inhibition assay	Inhibition of human NCI-H1563 cell growth in a cell viability assay, IC50=0.54246 μM	SANGER
他の多くの細胞株試験データをご覧になる場合はこちらをクリックして下さい

生物活性

製品説明

Akti-1/2 (Akt Inhibitor VIII) is a highly selective Akt1/Akt2 inhibitor with IC50 of 58 nM/210 nM, respectively, about 36-fold selectivity for Akt1 over Akt3. Akti-1/2 induces apoptosis.

Targets

Akt1 ^[1] (Cell-free assay)	Akt2 ^[1] (Cell-free assay)	Akt3 ^[1] (Cell-free assay)
58 nM	210 nM	2119 nM

In Vitro
In vitro	In a cell-based IPKA (C33A) assay, Akti-1/2 inhibits Akt1 and Akt2 with IC50 of 305 nM and 2086 nM, respectively. In HT29, MCF7, and A2780 cells, Akti-1/2 induces cell apoptosis by dramatically increasing caspase-3 activity. ^[1] In liver cells, Akti-1/2 blocks regulation of PEPCK, G6Pase expression, and FOXO1 activity. ^[2] Akti-1/2 also strongly potentiates PAR-1-mediated platelet aggregation by blocking PKB. ^[3] In HCC827, NCI-H522, NCI-1651, and PC-9 cells, Akti-1/2 inhibits cell growth with IC50 of 4.7 μM, 7.25 μM, and 9.5 μM, when in combination, Akti-1/2 causes enhanced inhibition of cell growth and apoptosis. ^[4]
Kinase Assay	Kinase screen
Kinase Assay	Briefly, all assays (25.5 μl at 21°C for 30 min) are performed using a Biomek 2000 Laboratory Automation Workstation in a 96-well format. Reactions contains 5–20 mU purified kinase along with substrate peptide or protein and are initiated by the addition of 10 mM MgAcetate and 5, 20, or 50 μM ATP ([γ-³³P]-ATP, 800 cpm/pmol).
細胞実験	細胞株	HCC827, NCI-H522, NCI-1651, and PC-9 cells
	濃度	~10 μM
	反応時間	96 h
	実験の流れ	The cell growth inhibitory effect of AKTi-1/2 is studied using the 96 h sulforhodamine B assay (SRB). Drug concentrations that inhibited 50% of cell growth (IC50) are calculated for each compound in GraphPad Prism 6.0 using non-linear regression analysis and sigmoidal dose–response (variable slope) equation.
実験結果図	Methods	Biomarkers	結果図	PMID
	Western blot	p-AKT / AKT / p-Foxo3a / p-GSK3β / p-p70S6K / p-S6 / p-4EBP1 / Cyclin D1 / Cyclin D2 / Cyclin D3 / p-Rb / p27		18725974
	Immunofluorescence	MCM2 / H3K9me2 / CD63		26637368

In Vivo
In Vivo	In mice, Akti-1/2 (50 mg/kg, i.p.) inhibits basal and IGF-stimulated Akt1 and Akt2 phosphorylation in lung. ^[1]
動物実験	動物モデル	C57BL/6 J mice
	投与量	50 mg/kg
	投与経路	i.p.

参考
[1] Lindsley CW, et al. Bioorg Med Chem Lett. 2005, 15(3), 761-764. [2] Logie L, et al. Diabetes. 2007, 56(9), 2218-2227. [3] Hunter RW, et al. J Thromb Haemost. 2008, 6(11), 1923-1932. [4] Puglisi M, et al. Lung Cancer. 2014, 85(2), 141-146. [5] Jeong SH, et al. Nat Commun. 2021 Jul 20;12(1):4405. + 展開

参考

+ 展開

化学情報

分子量	551.64	化学式	C₃₄H₂₉N₇O
CAS No.	612847-09-3	SDF	Download Akti-1/2 SDFをダウンロードする
Smiles	C1CN(CCC1N2C3=CC=CC=C3NC2=O)CC4=CC=C(C=C4)C5=C(N=C6C=C7C(=NC=N7)C=C6N5)C8=CC=CC=C8
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1年-80°Cin solvent
保管	3年-20°C粉	溶液の保管冷凍と解凍の繰り返しを避けるため小分けにしてください	1个月-20°Cin solvent

In vitro
Batch:

DMSO : 22 mg/mL ( (39.88 mM)；吸湿したDMSOは溶解度を減少させます。新しいDMSOをご使用ください。)

Water : Insoluble

Ethanol : Insoluble

モル濃度計算器

in vivo
Batch:

Add solvents to the product individually and in order.

投与溶液組成計算機

実験計算

モル濃度計算器

質量	濃度	体積	分子量
=	×	×

希釈計算器分子量計算器

投与溶液組成計算機(クリア溶液)

ステップ１：実験データを入力してください。（実験操作によるロスを考慮し、動物数を1匹分多くして計算・調製することを推奨します）

投与量 mg/kg 動物平均体重 g 投与体積（動物毎）μL 動物数匹

ステップ２：投与溶媒の組成を入力してください。（ロット毎に適した溶解組成が異なる場合があります。詳細については弊社までお問い合わせください）

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

計算結果：

投与溶媒濃度： mg/ml;

DMSOストック溶液調製方法： mg 試薬を μL DMSOに溶解する（濃度 mg/mL, 注：濃度が当該ロットのDMSO溶解度を超える場合はご連絡ください。 )

投与溶媒調製方法：Take μL DMSOストック溶液に μL PEG300，を加え、完全溶解後μL Tween 80，を加えて完全溶解させた後 μL ddH₂O，を加え完全に溶解させます。

投与溶媒調製方法：μL DMSOストック溶液に μL Corn oil，を加え、完全溶解。

注意：１.ストック溶液に沈殿、混濁などがないことをご確認ください；
２.順番通りに溶剤を加えてください。次のステップに進む前に溶液に沈殿、混濁などがないことを確認してから加えてください。ボルテックス、ソニケーション、水浴加熱など物理的な方法で溶解を早めることは可能です。

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):